Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

Recruiting N/A Interventional Study
Amyotrophic Lateral Sclerosis Neuromuscular Disease Stroke Tetraplegia/Tetraparesis Cervical Spinal Cord Injury Dysarthria
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 – 75
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
2 (estimated)
Sponsor
Paradromics · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with impaired communication as a result of severe loss of voluntary motor control; and (2) to provide cont…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of a progressive neuromuscular disease or a neurological injury. * Clinical diagnosis of anarthria or severe dysarthria. * Wheelchair dependent with severely impaired upper limb function. * Has a reliable method of communication and the ability to read and u…
Contacts

Paradromics Clinical Team

(512) 559 4120

clinical-team@paradromics.com

CONTACT